Cargando…

Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease

OBJECTIVE: To determine the effect of Vildagliptin in non-alcoholic, fatty liver disease patients with dyslipidemia. METHODS: A randomized placebo controlled trial was conducted at outpatient clinic of Medical Unit-I of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, in which fifty eight pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussain, Mazhar, Majeed Babar, Muhammad Zafar, Hussain, Muhammad Shahbaz, Akhtar, Lubna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216289/ https://www.ncbi.nlm.nih.gov/pubmed/28083033 http://dx.doi.org/10.12669/pjms.326.11133

Ejemplares similares

Neutrophil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients
por: Hussain, Mazhar, et al.
Publicado: (2017)

Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients
por: Hussain, Mazhar, et al.
Publicado: (2017)

Nebivolol Attenuates Neutrophil Lymphocyte Ratio: A Marker of Subclinical Inflammation in Hypertensive Patients
por: Hussain, Mazhar, et al.
Publicado: (2017)

Vitamin D supplementation improves FEV1 in patients of Bronchial Asthma
por: Babar, Muhammad Zafar Majeed, et al.
Publicado: (2017)

Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 mice
por: Mookkan, Jeyamurugan, et al.
Publicado: (2014)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Identification of Metabolic risk phenotypes predisposing to Non-Alcoholic Fatty Liver Disease in a Pakistani Cohort
por: Ghani, Rizwana Abdul, et al.
Publicado: (2017)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression
por: Perveen, Sajida, et al.
Publicado: (2018)

Perception of Non-Alcoholic Fatty Liver Disease: Real-Life Experience From Pakistan
por: Butt, Nazish, et al.
Publicado: (2021)

Biochemical assessment of metabolic associated fatty liver disease
por: Guerra-Ruiz, Armando R., et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Abe, Rose Anne M, et al.
Publicado: (2021)

Effect of sitagliptin and glimepiride on C-reactive protein (CRP) in overweight Type-2 diabetic patients
por: Hussain, Mazhar, et al.
Publicado: (2019)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
por: Virk, Ghazala S, et al.
Publicado: (2023)

Fatty acids characterization, oxidative perspectives and consumer acceptability of oil extracted from pre-treated chia (Salvia hispanica L.) seeds
por: Imran, Muhammad, et al.
Publicado: (2016)

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
por: Zeybel, Mujdat, et al.
Publicado: (2021)

Experimental models of metabolic and alcoholic fatty liver disease
por: Buyco, Delfin Gerard, et al.
Publicado: (2021)

Metabolic drivers of non-alcoholic fatty liver disease
por: Bence, Kendra K., et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias
por: Mangi, Muhammad A, et al.
Publicado: (2017)

Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal
por: Pardhe, Bashu Dev, et al.
Publicado: (2018)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Lifestyle interventions for non-alcoholic fatty liver disease
por: Ahmed, Idris Adewale, et al.
Publicado: (2019)

Effects of DA-5513 on alcohol metabolism and alcoholic fatty liver in rats
por: Yu, Jae Young, et al.
Publicado: (2018)

Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation
por: Ye, Jia-Hung, et al.
Publicado: (2016)

A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
por: Shahbaz, Mahrukh, et al.
Publicado: (2022)

Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents
por: Jain, Vandana, et al.
Publicado: (2018)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Metabolic Syndrome Is Associated With Advanced Liver Fibrosis Among Pediatric Patients With Non-alcoholic Fatty Liver Disease
por: Ting, Yi-Wen, et al.
Publicado: (2019)

Metabolic profiling of adolescent non-alcoholic fatty liver disease
por: Hartley, April, et al.
Publicado: (2019)

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
por: El Hadi, Hamza, et al.
Publicado: (2019)

Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease
por: Mun, Jeongeun, et al.
Publicado: (2019)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans
por: Medina-Urrutia, Aida, et al.
Publicado: (2020)

Momordica cochinchinensis Aril Ameliorates Diet-Induced Metabolic Dysfunction and Non-Alcoholic Fatty Liver by Modulating Gut Microbiota
por: Huang, Hsiu-Chen, et al.
Publicado: (2021)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Ahsan, Farah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gd4mvpen6s9so1re15vc20rqdf